Document is current
Any future updates will be listed below
-
Authors
Workman, Michael J.
Svendsen, Clive N.
-
Funding
Funding for this research was provided by:
National Institutes of Health (5UG3NS105703-03)
Paul G. Allen Family Foundation
- License Information
-
More Information
Article History
Received: 31 January 2020
Accepted: 7 April 2020
First Online: 22 April 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Cedars-Sinai owns a minority stock interest in Emulate, a company that produces microfluidic organ-chips. An officer of Cedars-Sinai also serves on Emulate’s Board of Directors. Emulate provided no financial support for this manuscript.
